Filing Flows

Filing Flows › Sanara MedTech (SMTI) › Next earnings date

Sanara MedTech (SMTI) earnings on Nov 11, 2026: what to expect

Sanara MedTech (SMTI) is expected to report earnings on Nov 11, 2026 (estimated), in 3 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of $0.02 (1 estimate) on revenue of $29.5M. It beat the EPS estimate in 50% of the quarters on record; Filing Flows' model gives it a 65% chance of beating next time.

Report dateNov 11, 2026 (estimated)
Days to go3
EPS estimate$0.02
Revenue estimate$29.5M
Beat rate50%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Sanara MedTech: revenue lines, growth year over year, Q2 2026Sanara MedTech: revenue lines, growth year over year, Q2 2026Revenue+9%Soft Tissue Repair Products+11%Bone Fusion Products-8%

The last report

Sanara MedTech reported revenue of $28.1M for the second quarter 2026 (+9% Y/Y), net loss $453K: Soft Tissue Repair Products $25.2M, Bone Fusion Products $2.9M. How it makes money → · Every quarter →

Sanara MedTech: EPS against the estimate, last 4 reportsSanara MedTech: EPS against the estimate, last 4 reportsEstimateReported−$0.21−$3.52Nov 25$0.11−$0.19Mar 26−$0.22$0.04May 26−$0.07$0.09Aug 26
Latest (Aug 26): Estimate −$0.07, Reported $0.09.
SMTI: the stock's move on each reportSMTI: the stock's move on each reportAug 11, 2026+0.2%May 11, 2026+11.1%Mar 24, 2026-10.9%Nov 12, 2025-30.1%

Sanara MedTech's latest quarter

Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.

Questions

When does SMTI report earnings?

Sanara MedTech is expected to report on Nov 11, 2026 (estimated).

What are analysts expecting from Sanara MedTech?

EPS of $0.02 and revenue of $29.5M for the quarter.

Does Sanara MedTech usually beat earnings?

It beat the consensus EPS estimate in 50% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.